Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation

American Journal of Obstetrics and Gynecology

Volumn 215, Issue 1, 2016, Pages 87.e1-87.e17

  Tsiakkas, Andreas ^a   Saiid, Youssef ^a   Wright, Alan ^b   Wright, David ^b   Nicolaides, Kypros H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Bayes theorem; mean arterial pressure; placental growth factor; preeclampsia; pyramid of pregnancy care; soluble fms like tyrosine kinase 1; survival model; third trimester screening; uterine artery Doppler

Indexed keywords

PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ARTICLE; BAYES THEOREM; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MEAN ARTERIAL PRESSURE; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; RISK FACTOR; THIRD TRIMESTER PREGNANCY; UTERINE ARTERY PULSATILITY INDEX; ADULT; BLOOD; DIAGNOSTIC IMAGING; MASS SCREENING; PHYSIOLOGY; PRE-ECLAMPSIA; PREDICTIVE VALUE; PREGNANCY; PROCEDURES; RISK ASSESSMENT; STATISTICAL MODEL; UTERINE ARTERY;

ADULT; BIOMARKERS; FEMALE; GESTATIONAL AGE; HUMANS; MASS SCREENING; MODELS, STATISTICAL; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RISK ASSESSMENT; UTERINE ARTERY;

EID: 84971534498     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.02.016     Document Type: Article

References (40)

1. World Health Organization Make every mother and child count 2005 World Health Report Geneva
2. M. Knight, S. Kenyon, P. Brocklehurst, J. Neilson, J. Shakespeare, and J.J. Kurinczuk on behalf of MBRRACEUK. Saving Lives, Improving Mothers' Care: lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-12 2014 National Perinatal Epidemiology Unit, University of Oxford Oxford (United Kingdom)
3. E. Bujold, S. Roberge, Y. Lacasse, and et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis Obstet Gynecol 116 2010 402 414
4. S. Roberge, K. Nicolaides, S. Demers, P. Villa, and E. Bujold Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis Ultrasound Obstet Gynecol 41 2013 491 499
5. C.M. Koopmans, D. Bijlenga, H. Groen, and et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial Lancet 374 2009 979 988
6. American College of Obstetricians and Gynecologists First-trimester risk assessment for early-onset preeclampsia. Committee opinion no. 638 Obstet Gynecol 126 2015 e25 e27
7. National Collaborating Centre for Women's and Children's Health (UK) Hypertension in pregnancy: the management of hypertensive disorders during pregnancy 2010 RCOG Press London
8. D. Wright, A. Syngelaki, R. Akolekar, L.C. Poon, and K.H. Nicolaides Competing risks model in screening for preeclampsia by maternal characteristics and medical history Am J Obstet Gynecol 213 2015 62.e1 62.e10
9. N. O'Gorman, D. Wright, A. Syngelaki, and et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks' gestation Am J Obstet Gynecol 214 2016 103.e1 103.e12
10. D.M. Gallo, D. Wright, R. Akolekar, L.C. Poon, and K.H. Nicolaides Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation Am J Obstet Gynecol 2015 10.1016/j.ajog.2015.11.016
11. H. Li, H. Gudnason, P. Olofsson, M. Dubiel, and S. Gudmundsson Increased uterine artery vascular impedance is related to adverse outcome of pregnancy but is present in only one third of late third-trimester pre-eclamptic women Ultrasound Obstet Gynecol 25 2005 459 463
12. T. Ghi, A. Youssef, M. Piva, and et al. The prognostic role of uterine artery Doppler studies in patients with late-onset preeclampsia Am J Obstet Gynecol 201 2009 36.e1 36.e5
13. S. Verlohren, I. Herraiz, O. Lapaire, and et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients Am J Obstet Gynecol 206 2012 58.e1 58.e8
14. S. Rana, C.E. Powe, S. Salahuddin, and et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia Circulation 125 2012 911 919
15. J. Sibiude, J. Guibourdenche, M.D. Dionne, and et al. Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction PLoS One 7 2012 e50208
16. A. Ohkuchi, C. Hirashima, K. Takahashi, H. Suzuki, S. Matsubara, and M. Suzuki Onset threshold of the plasma levels of soluble fms-like tyrosine kinase-1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation Hypertens Res 36 2013 1073 1080
17. L.C. Chappell, S. Duckworth, P.T. Seed, and et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicentre study Circulation 128 2013 2121 2131
18. A. Wright, D. Wright, A. Ispas, L.C. Poon, and K.H. Nicolaides Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history Ultrasound Obstet Gynecol 45 2015 698 706
19. A. Tayyar, L. Guerra, A. Wright, D. Wright, and K.H. Nicolaides Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history Ultrasound Obstet Gynecol 45 2015 689 697
20. A. Tsiakkas, N. Duvdevani, A. Wright, D. Wright, and K.H. Nicolaides Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history Ultrasound Obstet Gynecol 45 2015 591 598
21. A. Tsiakkas, N. Duvdevani, A. Wright, D. Wright, and K.H. Nicolaides Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history Ultrasound Obstet Gynecol 45 2015 584 590
22. S. Garcia-Tizon Larroca, A. Tayyar, L.C. Poon, D. Wright, and K.H. Nicolaides Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30-33 weeks' gestation Fetal Diagn Ther 36 2014 9 17
23. G. Albaiges, H. Missfelder-Lobos, C. Lees, M. Parra, and K.H. Nicolaides One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation Obstet Gynecol 96 2000 559 564
24. L.C. Poon, N.A. Zymeri, A. Zamprakou, A. Syngelaki, and K.H. Nicolaides Protocol for measurement of mean arterial pressure at 11-13 weeks' gestation Fetal Diagn Ther 31 2012 42 48
25. H.P. Robinson, and J.E. Fleming A critical evaluation of sonar crown rump length measurements Br J Obstet Gynaecol 82 1975 702 710
26. R.J. Snijders, and K.H. Nicolaides Fetal biometry at 14-40 weeks' gestation Ultrasound Obstet Gynecol 4 1994 34 48
27. M.A. Brown, M.D. Lindheimer, M. de Swiet, A. Van Assche, and J.M. Moutquin The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy 20 2001 IX XIV
28. D. Wright, R. Akolekar, A. Syngelaki, L.C. Poon, and K.H. Nicolaides A competing risks model in early screening for preeclampsia Fetal Diagn Ther 32 2012 171 178
29. R Development Core Team. R. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2011. Available at: http://www.R-project.org/. Accessed October 10, 2015.
30. Therneau T. A package for survival analysis in S. R package version 2.37-7. 2014. Available at: http://CRAN.R-project.org/package=survival. Accessed October 10, 2015.
31. X. Robin, N. Turck, A. Hainard, and et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves BMC Bioinformatics 12 2011 77 84
32. T. Chaiworapongsa, R. Romero, Z.A. Savasan, and et al. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia J Matern Fetal Neonatal Med 24 2011 1187 1207
33. K.H. Nicolaides Turning the pyramid of prenatal care Fetal Diagn Ther 29 2011 183 196
34. G.A. Witlin, G.R. Saade, F.M. Mattar, and B.M. Sibai Predictors of neonatal outcome in women with severe pre-eclampsia or eclampsia between 24 and 33 weeks' gestation Am J Obstet Gynecol 182 2000 607 611
35. L. Bellamy, J.P. Casas, A.D. Hingorani, and D.J. Williams Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis BMJ 335 2007 974
36. P. von Dadelszen, L.A. Magee, and J.M. Roberts Subclassification of pre-eclampsia Hypertens Pregnancy 22 2003 143 148
37. J.S. Moldenhauer, J. Stanek, C. Warshak, J. Khoury, and B. Sibai The frequency and severity of placental findings in women with pre-eclampsia are gestational age dependent Am J Obstet Gynecol 189 2003 1173 1177
38. C.K. Yu, O. Khouri, N. Onwudiwe, Y. Spiliopoulos, and K.H. Nicolaides Fetal Medicine Foundation Second-Trimester Screening Group. Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age Ultrasound Obstet Gynecol 31 2008 310 313
39. L.C. Poon, N. Volpe, B. Muto, C.K. Yu, A. Syngelaki, and K.H. Nicolaides Second-trimester uterine artery Doppler in the prediction of stillbirths Fetal Diagn Ther 33 2013 28 35
40. S. Andrietti, M. Silva, A. Wright, D. Wright, and K.H. Nicolaides Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 35-37 weeks' gestation Ultrasound Obstet Gynecol 2015 10.1002/uog.15812